NCT03521154 · ADVERSE EVENTS
Adverse events
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
Adverse events occurred during the study; they are not necessarily caused by treatment. Serious events are not interchangeable with severe/grade 3–4 events. These safety populations may differ from efficacy populations.
- Collection time frame
- From the time of signature of informed consent throughout the treatment period (maximum actual duration of 62.4 and 56.2 months for Osimertinib and Placebo respectively) up to and including 28 day follow up following last dose of study drug.
- Other-event reporting threshold
- 5%
The initial dose of osimertinib/placebo 80 mg QD could be reduced to 40 mg QD to allow for management of study treatment-related toxicities. Once the dose of osimertinib/placebo was reduced to 40 mg QD, the patient was to remain on the reduced dose until termination from study treatment
| Safety group | Serious events | Other events | Deaths |
|---|---|---|---|
| Osimertinib | 55 / 143 | 129 / 143 | 28 / 143 |
| Placebo | 11 / 73 | 54 / 73 | 15 / 73 |
Serious adverse events
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA 26.1
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 143
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 73
- num Events
- 0
- term
- Large intestine polyp
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA 26.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 143
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 73
- num Events
- 1
- term
- Nausea
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA 26.1
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 143
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 73
- num Events
- 0
- term
- Oesophageal stenosis
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- General disorders
- source Vocabulary
- MedDRA 26.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 143
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 73
- num Events
- 1
- term
- Malaise
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Hepatobiliary disorders
- source Vocabulary
- MedDRA 26.1
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 143
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 73
- num Events
- 0
- term
- Hepatic failure
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Infections and infestations
- source Vocabulary
- MedDRA 26.1
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 143
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 73
- num Events
- 0
- term
- Bacterial pyelonephritis
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Infections and infestations
- source Vocabulary
- MedDRA 26.1
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 143
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 73
- num Events
- 0
- term
- Biliary tract infection
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Infections and infestations
- source Vocabulary
- MedDRA 26.1
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 143
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 73
- num Events
- 0
- term
- Bronchitis
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- MedDRA 26.1
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 143
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 73
- num Events
- 0
- term
- Anaemia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Infections and infestations
- source Vocabulary
- MedDRA 26.1
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 143
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 73
- num Events
- 0
- term
- Covid-19
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Infections and infestations
- source Vocabulary
- MedDRA 26.1
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 143
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 73
- num Events
- 0
- term
- Chronic hepatitis b
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Infections and infestations
- source Vocabulary
- MedDRA 26.1
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 143
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 73
- num Events
- 0
- term
- Dengue fever
Other reported adverse events
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA 26.1
- stats
- group Id
- EG000
- num Affected
- 17
- num At Risk
- 143
- num Events
- 20
- group Id
- EG001
- num Affected
- 2
- num At Risk
- 73
- num Events
- 2
- term
- Stomatitis
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- MedDRA 26.1
- stats
- group Id
- EG000
- num Affected
- 13
- num At Risk
- 143
- num Events
- 16
- group Id
- EG001
- num Affected
- 3
- num At Risk
- 73
- num Events
- 3
- term
- Anaemia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Infections and infestations
- source Vocabulary
- MedDRA 26.1
- stats
- group Id
- EG000
- num Affected
- 28
- num At Risk
- 143
- num Events
- 28
- group Id
- EG001
- num Affected
- 6
- num At Risk
- 73
- num Events
- 6
- term
- Covid-19
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Infections and infestations
- source Vocabulary
- MedDRA 26.1
- stats
- group Id
- EG000
- num Affected
- 13
- num At Risk
- 143
- num Events
- 13
- group Id
- EG001
- num Affected
- 2
- num At Risk
- 73
- num Events
- 2
- term
- Herpes zoster
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Infections and infestations
- source Vocabulary
- MedDRA 26.1
- stats
- group Id
- EG000
- num Affected
- 8
- num At Risk
- 143
- num Events
- 9
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 73
- num Events
- 0
- term
- Nasopharyngitis
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Infections and infestations
- source Vocabulary
- MedDRA 26.1
- stats
- group Id
- EG000
- num Affected
- 24
- num At Risk
- 143
- num Events
- 29
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 73
- num Events
- 1
- term
- Paronychia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Infections and infestations
- source Vocabulary
- MedDRA 26.1
- stats
- group Id
- EG000
- num Affected
- 10
- num At Risk
- 143
- num Events
- 10
- group Id
- EG001
- num Affected
- 3
- num At Risk
- 73
- num Events
- 5
- term
- Pneumonia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Infections and infestations
- source Vocabulary
- MedDRA 26.1
- stats
- group Id
- EG000
- num Affected
- 10
- num At Risk
- 143
- num Events
- 18
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 73
- num Events
- 1
- term
- Upper respiratory tract infection
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Infections and infestations
- source Vocabulary
- MedDRA 26.1
- stats
- group Id
- EG000
- num Affected
- 11
- num At Risk
- 143
- num Events
- 13
- group Id
- EG001
- num Affected
- 2
- num At Risk
- 73
- num Events
- 2
- term
- Urinary tract infection
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Injury, poisoning and procedural complications
- source Vocabulary
- MedDRA 26.1
- stats
- group Id
- EG000
- num Affected
- 55
- num At Risk
- 143
- num Events
- 55
- group Id
- EG001
- num Affected
- 26
- num At Risk
- 73
- num Events
- 27
- term
- Radiation pneumonitis
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Investigations
- source Vocabulary
- MedDRA 26.1
- stats
- group Id
- EG000
- num Affected
- 10
- num At Risk
- 143
- num Events
- 12
- group Id
- EG001
- num Affected
- 2
- num At Risk
- 73
- num Events
- 2
- term
- Alanine aminotransferase increased
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Investigations
- source Vocabulary
- MedDRA 26.1
- stats
- group Id
- EG000
- num Affected
- 8
- num At Risk
- 143
- num Events
- 11
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 73
- num Events
- 1
- term
- Aspartate aminotransferase increased
Complete source fields
- description
- The initial dose of osimertinib/placebo 80 mg QD could be reduced to 40 mg QD to allow for management of study treatment-related toxicities. Once the dose of osimertinib/placebo was reduced to 40 mg QD, the patient was to remain on the reduced dose until termination from study treatment
- event Groups
- deaths Num Affected
- 28
- deaths Num At Risk
- 143
- description
- 80mg once daily tablet
- id
- EG000
- other Num Affected
- 129
- other Num At Risk
- 143
- serious Num Affected
- 55
- serious Num At Risk
- 143
- title
- Osimertinib
- deaths Num Affected
- 15
- deaths Num At Risk
- 73
- description
- Matching Placebo
- id
- EG001
- other Num Affected
- 54
- other Num At Risk
- 73
- serious Num Affected
- 11
- serious Num At Risk
- 73
- title
- Placebo
- frequency Threshold
- 5
- other Events
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA 26.1
- stats
- group Id
- EG000
- num Affected
- 17
- num At Risk
- 143
- num Events
- 20
- group Id
- EG001
- num Affected
- 2
- num At Risk
- 73
- num Events
- 2
- term
- Stomatitis
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- MedDRA 26.1
- stats
- group Id
- EG000
- num Affected
- 13
- num At Risk
- 143
- num Events
- 16
- group Id
- EG001
- num Affected
- 3
- num At Risk
- 73
- num Events
- 3
- term
- Anaemia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Infections and infestations
- source Vocabulary
- MedDRA 26.1
- stats
- group Id
- EG000
- num Affected
- 28
- num At Risk
- 143
- num Events
- 28
- group Id
- EG001
- num Affected
- 6
- num At Risk
- 73
- num Events
- 6
- term
- Covid-19
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Infections and infestations
- source Vocabulary
- MedDRA 26.1
- stats
- group Id
- EG000
- num Affected
- 13
- num At Risk
- 143
- num Events
- 13
- group Id
- EG001
- num Affected
- 2
- num At Risk
- 73
- num Events
- 2
- term
- Herpes zoster
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Infections and infestations
- source Vocabulary
- MedDRA 26.1
- stats
- group Id
- EG000
- num Affected
- 8
- num At Risk
- 143
- num Events
- 9
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 73
- num Events
- 0
- term
- Nasopharyngitis
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Infections and infestations
- source Vocabulary
- MedDRA 26.1
- stats
- group Id
- EG000
- num Affected
- 24
- num At Risk
- 143
- num Events
- 29
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 73
- num Events
- 1
- term
- Paronychia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Infections and infestations
- source Vocabulary
- MedDRA 26.1
- stats
- group Id
- EG000
- num Affected
- 10
- num At Risk
- 143
- num Events
- 10
- group Id
- EG001
- num Affected
- 3
- num At Risk
- 73
- num Events
- 5
- term
- Pneumonia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Infections and infestations
- source Vocabulary
- MedDRA 26.1
- stats
- group Id
- EG000
- num Affected
- 10
- num At Risk
- 143
- num Events
- 18
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 73
- num Events
- 1
- term
- Upper respiratory tract infection
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Infections and infestations
- source Vocabulary
- MedDRA 26.1
- stats
- group Id
- EG000
- num Affected
- 11
- num At Risk
- 143
- num Events
- 13
- group Id
- EG001
- num Affected
- 2
- num At Risk
- 73
- num Events
- 2
- term
- Urinary tract infection
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Injury, poisoning and procedural complications
- source Vocabulary
- MedDRA 26.1
- stats
- group Id
- EG000
- num Affected
- 55
- num At Risk
- 143
- num Events
- 55
- group Id
- EG001
- num Affected
- 26
- num At Risk
- 73
- num Events
- 27
- term
- Radiation pneumonitis
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Investigations
- source Vocabulary
- MedDRA 26.1
- stats
- group Id
- EG000
- num Affected
- 10
- num At Risk
- 143
- num Events
- 12
- group Id
- EG001
- num Affected
- 2
- num At Risk
- 73
- num Events
- 2
- term
- Alanine aminotransferase increased
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Investigations
- source Vocabulary
- MedDRA 26.1
- stats
- group Id
- EG000
- num Affected
- 8
- num At Risk
- 143
- num Events
- 11
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 73
- num Events
- 1
- term
- Aspartate aminotransferase increased
- serious Events
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA 26.1
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 143
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 73
- num Events
- 0
- term
- Large intestine polyp
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA 26.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 143
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 73
- num Events
- 1
- term
- Nausea
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA 26.1
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 143
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 73
- num Events
- 0
- term
- Oesophageal stenosis
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- General disorders
- source Vocabulary
- MedDRA 26.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 143
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 73
- num Events
- 1
- term
- Malaise
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Hepatobiliary disorders
- source Vocabulary
- MedDRA 26.1
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 143
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 73
- num Events
- 0
- term
- Hepatic failure
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Infections and infestations
- source Vocabulary
- MedDRA 26.1
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 143
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 73
- num Events
- 0
- term
- Bacterial pyelonephritis
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Infections and infestations
- source Vocabulary
- MedDRA 26.1
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 143
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 73
- num Events
- 0
- term
- Biliary tract infection
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Infections and infestations
- source Vocabulary
- MedDRA 26.1
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 143
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 73
- num Events
- 0
- term
- Bronchitis
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- MedDRA 26.1
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 143
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 73
- num Events
- 0
- term
- Anaemia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Infections and infestations
- source Vocabulary
- MedDRA 26.1
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 143
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 73
- num Events
- 0
- term
- Covid-19
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Infections and infestations
- source Vocabulary
- MedDRA 26.1
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 143
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 73
- num Events
- 0
- term
- Chronic hepatitis b
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Infections and infestations
- source Vocabulary
- MedDRA 26.1
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 143
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 73
- num Events
- 0
- term
- Dengue fever
- time Frame
- From the time of signature of informed consent throughout the treatment period (maximum actual duration of 62.4 and 56.2 months for Osimertinib and Placebo respectively) up to and including 28 day follow up following last dose of study drug.
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice
Triangle